Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,908,299
-
Share change
-
+9,788,228
-
Total reported value
-
$122,413,000
-
Price per share
-
$11.37
-
Number of holders
-
44
-
Value change
-
+$109,677,000
-
Number of buys
-
39
Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q4 2020
As of 31 Dec 2020 MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,908,299 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, Ghost Tree Capital, LLC, Cormorant Asset Management, LP, and Avidity Partners Management LP.
This table shows 44 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.